635 related articles for article (PubMed ID: 32725890)
1. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
[TBL] [Abstract][Full Text] [Related]
2. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study.
Xu W; Huang C; Fei L; Li Q; Chen L
Clin Interv Aging; 2021; 16():675-685. PubMed ID: 33911856
[TBL] [Abstract][Full Text] [Related]
3. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
Wang Q; Zhao H; Liu LG; Wang YB; Zhang T; Li MH; Xu YL; Gao GJ; Xiong HF; Fan Y; Cao Y; Ding R; Wang JJ; Cheng C; Xie W
Mil Med Res; 2020 Jun; 7(1):28. PubMed ID: 32507110
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study.
Zeng QL; Yu ZJ; Ji F; Li GM; Zhang GF; Xu JH; Lin WB; Zhang GQ; Li GT; Cui GL; Wang FS
BMC Infect Dis; 2021 Aug; 21(1):818. PubMed ID: 34399709
[TBL] [Abstract][Full Text] [Related]
5. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
[TBL] [Abstract][Full Text] [Related]
6. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Abnormal liver function tests.
Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study.
Wang J; Zhu L; Xue L; Liu L; Yan X; Yan X; Huang S; Zhang B; Xu T; Li C; Ji F; Ming F; Zhao Y; Cheng J; Shao H; Chen K; Zhao XA; Sang D; Zhao H; Guan X; Chen X; Chen Y; Liu J; Huang R; Zhu C; Wu C
J Med Virol; 2021 Jun; 93(6):3305-3311. PubMed ID: 33174624
[TBL] [Abstract][Full Text] [Related]
11. Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19.
Lv Y; Zhao X; Wang Y; Zhu J; Ma C; Feng X; Ma Y; Zheng Y; Yang L; Han G; Xie H
Front Med (Lausanne); 2021; 8():639855. PubMed ID: 34179034
[No Abstract] [Full Text] [Related]
12. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China.
Lei F; Liu YM; Zhou F; Qin JJ; Zhang P; Zhu L; Zhang XJ; Cai J; Lin L; Ouyang S; Wang X; Yang C; Cheng X; Liu W; Li H; Xie J; Wu B; Luo H; Xiao F; Chen J; Tao L; Cheng G; She ZG; Zhou J; Wang H; Lin J; Luo P; Fu S; Zhou J; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu L; Chen G; Li H; Huang X; Zhang BH; Yuan Y
Hepatology; 2020 Aug; 72(2):389-398. PubMed ID: 32359177
[TBL] [Abstract][Full Text] [Related]
13. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study.
Weber S; Hellmuth JC; Scherer C; Muenchhoff M; Mayerle J; Gerbes AL
Gut; 2021 Oct; 70(10):1925-1932. PubMed ID: 33514597
[TBL] [Abstract][Full Text] [Related]
14. Liver Biochemistries in Hospitalized Patients With COVID-19.
Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
[TBL] [Abstract][Full Text] [Related]
15. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
[TBL] [Abstract][Full Text] [Related]
16. The effect of liver test abnormalities on the prognosis of COVID-19.
Medetalibeyoglu A; Catma Y; Senkal N; Ormeci A; Cavus B; Kose M; Bayramlar OF; Yildiz G; Akyuz F; Kaymakoglu S; Tukek T
Ann Hepatol; 2020; 19(6):614-621. PubMed ID: 32920162
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of baseline liver biochemical parameters in 324 cases with novel coronavirus pneumonia in Shanghai area].
Qian ZP; Mei X; Zhang YY; Zou Y; Zhang ZG; Zhu H; Guo HY; Liu Y; Ling Y; Zhang XY; Wang JF; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):229-233. PubMed ID: 32270660
[No Abstract] [Full Text] [Related]
18. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.
Wu Y; Li H; Guo X; Yoshida EM; Mendez-Sanchez N; Levi Sandri GB; Teschke R; Romeiro FG; Shukla A; Qi X
Hepatol Int; 2020 Sep; 14(5):621-637. PubMed ID: 32710250
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hepatic enzymes activities in COVID-19 patients.
Hwaiz R; Merza M; Hamad B; HamaSalih S; Mohammed M; Hama H
Int Immunopharmacol; 2021 Aug; 97():107701. PubMed ID: 33930704
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
